No discrete drug-like molecular target

The designation No discrete drug-like molecular target refers to a category of therapeutic agents that do not achieve their pharmacological effect by binding to a specific biological macromolecule like a receptor, enzyme, or ion channel. Instead, these agents function through broad physical or chemical mechanisms. For example, antacids such as aluminum hydroxide or magnesium hydroxide work by directly neutralizing gastric hydrochloric acid in a stoichiometric chemical reaction (StatPearls, 2023). Similarly, osmotic laxatives like polyethylene glycol and osmotic diuretics like mannitol function by creating a concentration gradient that physically draws water into the intestinal lumen or renal tubules, respectively (PubMed, 2022). Other agents in this category include activated charcoal, which acts as a physical adsorbent to trap toxins in the gastrointestinal tract, and simethicone, which reduces the surface tension of gas bubbles to facilitate their expulsion (DrugBank, 2024). Because these treatments lack a specific molecular lock-and-key interaction, they are often characterized by high dose requirements and a lack of traditional structure-activity relationships. This classification is vital for pharmacological databases to distinguish between targeted molecular therapies and those governed by the laws of physics and general chemistry (ChEMBL, 2024).

Other names

Non-specific targetNon-molecular targetPhysical/chemical mechanism of actionNon-proteinaceous target

Drugs associated with this classification exert their effects through non-specific chemical or physical processes, such as direct acid-base neutralization, the creation of osmotic gradients, physical adsorption of molecules, or the alteration of physical surface tension, rather than through stereospecific binding to a protein or nucleic acid receptor.